Lotus Eye Hospital and Institute Dirección
Dirección controles de criterios 4/4
El CEO de Lotus Eye Hospital and Institute es Kuttapalayam Ramalingam, nombrado en Aug 2020, tiene una permanencia de 4.25 años. posee directamente un 1.43% de las acciones de la empresa, con un valor de ₹19.07M. La antigüedad media del equipo directivo y de la junta directiva es de 4.2 años y 3.8 años, respectivamente.
Información clave
Kuttapalayam Ramalingam
Chief Executive Officer (CEO)
₹1.2m
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 4.3yrs |
| Participación del CEO | 1.4% |
| Permanencia media de la dirección | 4.2yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06CEO
Kuttapalayam Ramalingam (74 yo)
4.3yrs
Permanencia
₹1,200,000
Compensación
Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | 4.3yrs | ₹1.20m | 1.43% ₹ 19.1m | |
| Chief Financial Officer | 2.5yrs | ₹1.70m | sin datos | |
| Company Secretary & Compliance Officer | 2.8yrs | ₹1.08m | sin datos | |
| MD & Director | 4.2yrs | ₹3.09m | 18.84% ₹ 250.4m | |
| Vice President of Administration | 6.5yrs | sin datos | 0% ₹ 0 |
4.2yrs
Permanencia media
67yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de LOTUSEYE se considera experimentado (4.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | 3.8yrs | ₹1.20m | 1.43% ₹ 19.1m | |
| MD & Director | 5yrs | ₹3.09m | 18.84% ₹ 250.4m | |
| Vice President of Administration | 4.8yrs | sin datos | 0% ₹ 0 | |
| Chairman of the Board | 8.5yrs | ₹150.00k | 18.78% ₹ 249.6m | |
| Independent Director | 3.8yrs | ₹200.00k | sin datos | |
| Independent Non-Executive Director | 1.9yrs | ₹200.00k | sin datos | |
| Independent Non-Executive Director | 1.8yrs | ₹175.00k | sin datos |
3.8yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: La junta directiva de LOTUSEYE se considera experimentada (3.8 años de antigüedad promedio).